MARÍA MAGDALENA
SALCEDO PLAZA
Profesora asociada de Ciencias de la Salud
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (27)
2024
-
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Annals of Hepatology, Vol. 29, Núm. 3
-
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Liver International, Vol. 44, Núm. 2, pp. 279-285
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
2022
-
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682
-
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
Alimentary Pharmacology and Therapeutics, Vol. 56, Núm. 1, pp. 131-143
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
-
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort
Transplant International, Vol. 35
-
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis
Hepatology Communications, Vol. 6, Núm. 6, pp. 1392-1402
-
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study
Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261
2021
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
-
Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
Journal of Hepatology
2020
-
Increased incidence of COVID-19 among liver transplant patients in Europe
Transplant International
-
Letter: unknown denominator and misleading conclusions in COVID-19
Alimentary Pharmacology and Therapeutics
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
-
Influence of donor liver CYP3A4∗20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients
Pharmacogenetics and Genomics, Vol. 28, Núm. 2, pp. 41-48
2017
-
Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Liver Transplantation, Vol. 23, Núm. 5, pp. 645-651
-
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Hepatology, Vol. 65, Núm. 6, pp. 1810-1822
2016
-
Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))
Journal of Hepatology
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498